US Patent Issued to Prolacta Bioscience on July 22 for "Compositions and methods for treatment of inflammatory and immune diseases" (California Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,721, issued on July 22, was assigned to Prolacta Bioscience Inc. (Duarte, Calif.).

"Compositions and methods for treatment of inflammatory and immune diseases" was invented by David N. Cook (City of Industry, Calif.), Gregory McKenzie (City of Industry, Calif.) and Julie E. Button (City of Industry, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions, methods, strategies, kits, and articles of manufacture that are useful, inter alia, in the treatment or prevention of diseases or conditions such as those which may be associated with inflammation, infection, allergy, immune dysfunction, or dysbiosis of the intestinal...